{
    "clinical_study": {
        "@rank": "114234", 
        "brief_summary": {
            "textblock": "The investigators hypothesize that the physiological effects of milk on satiety and glycemic\n      control are mediated by the interaction between its macronutrient components by both\n      insulin-dependent and independent mechanisms."
        }, 
        "brief_title": "Mechanism of Action of Milk and Its Components on Glycemic Control in Healthy Young Men", 
        "condition": [
            "Glycemic Control", 
            "Gastrointestinal Hormone Response", 
            "Healthy Young Men"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy young men\n\n          -  20-30 years of age\n\n          -  BMI:  20-24.9 kg/m2\n\n        Exclusion Criteria:\n\n          -  Smoking\n\n          -  Dieting\n\n          -  Skipping breakfast\n\n          -  Lactose intolerance or allergies to milk\n\n          -  Taking medications that may affect glucose metabolism or appetite\n\n          -  Diabetes (fasting blood glucose \u2265 7.0 mmol/L) or other metabolic diseases"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01812967", 
            "org_study_id": "Milk Components Study"
        }, 
        "intervention": [
            {
                "intervention_name": "Milk Fat", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "intervention_name": "Milk Protein", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "intervention_name": "Lactose", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "description": "Commercially available milk from the grocery store", 
                "intervention_name": "Whole milk (3.25% M.F.(", 
                "intervention_type": "Other"
            }, 
            {
                "description": "Added lactose + fat + protein together to form a mixture", 
                "intervention_name": "Simulated Milk Beverage", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "lastchanged_date": "March 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5S 3E2"
                }, 
                "name": "University of Toronto"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "other_outcome": {
            "description": "Gatrointestinal hormones measured include plasma concentrations of glucagon-like peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY), cholecystokinin (CCK), and ghrelin.\nGastric emptying is assessed indirectly by adding 1.5 g of paracetamol (acetaminophen) to each beverage and measuring plasma paracetamol concentrations.", 
            "measure": "Gastrointestinal hormones and gastric emptying rate", 
            "safety_issue": "No", 
            "time_frame": "0-180 min"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada:  University of Toronto Research Ethics Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Glucose", 
            "safety_issue": "No", 
            "time_frame": "0-180 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01812967"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Toronto", 
            "investigator_full_name": "G. Harvey Anderson", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Insulin", 
            "safety_issue": "No", 
            "time_frame": "0-180 min"
        }, 
        "source": "University of Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Toronto", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}